Patients with HIV with Burkitt's lymphoma have a worse outcome than those with diffuse large-cell lymphoma also in the highly active antiretroviral therapy era.

@article{Spina2005PatientsWH,
  title={Patients with HIV with Burkitt's lymphoma have a worse outcome than those with diffuse large-cell lymphoma also in the highly active antiretroviral therapy era.},
  author={Michele Attilio Spina and Cecilia Simonelli and Renato Talamini and Umberto Tirelli},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2005},
  volume={23 31},
  pages={
          8132-3; author reply 8133-4
        }
}
BETA

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-8 OF 8 CITATIONS

Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma.

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2015
VIEW 14 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Modern management of non-Hodgkin lymphoma in HIV-infected patients.

VIEW 8 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Ki-67 is a strong predictor of central nervous system relapse in patients with mantle cell lymphoma (MCL).

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2014

Similar Papers

Loading similar papers…